{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T15:12:17Z","timestamp":1794928337537,"version":"4.9.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T00:00:00Z","timestamp":1669161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T00:00:00Z","timestamp":1669161600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Gold-Bridge Funds for Beijing","award":["ZZ21054"],"award-info":[{"award-number":["ZZ21054"]}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7204249"],"award-info":[{"award-number":["7204249"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Beijing Talents Fund","award":["2018000021469G198"],"award-info":[{"award-number":["2018000021469G198"]}]},{"name":"Aerospace Center Hospital Foundation","award":["YN201710"],"award-info":[{"award-number":["YN201710"]}]},{"name":"Aerospace Center Hospital Youth Foundation","award":["2022QN06"],"award-info":[{"award-number":["2022QN06"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>This study aimed to identify the diagnostic accuracy of combined ultrasonography (US) and computed tomography (CT) in evaluating the tumor burden of pseudomyxoma peritonei (PMP). Besides, we assessed the ability of this combination to predict the likelihood of complete resection.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This retrospective study involved 504 patients diagnosed with PMP and scheduled for cytoreduction surgery. We compared tumor burden\u2014quantified as peritoneal cancer index (PCI) by preoperative US and CT (US-CT-PCI)\u2014with surgical findings. Next, we assessed the prognostic value of US-CT PCI and imaging features in determining the completeness of cytoreduction (CCR) score using multivariate analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>US-CT PCI demonstrated a high PCI evaluation accuracy under moderate tumor burden. Higher US-CT PCI could predict incomplete resection. In addition, we identified imaging features such as mesenteric involvement as an independent predictor of incomplete resection (hazard ratio (HR) = 2.006; <jats:italic>p<\/jats:italic> = 0.007).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>US-CT PCI allowed us to predict the completeness of cytoreductive surgery in patients with PMP. Moreover, the combined US and CT imaging detected several features indicating incomplete cytoreduction.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Key Points<\/jats:title>\n                <jats:p><jats:italic>\u2022 Ultrasonography (US) can act as a complementary diagnostic modality in peritoneal cancer index (PCI) evaluation by combining CT in the small bowel area and US in the abdominal area.<\/jats:italic><\/jats:p>\n                <jats:p><jats:italic>\u2022 A modified peritoneal cancer index (US-CT PCI) helps preoperatively evaluate tumor burden with high accuracy and allows to predict incomplete resection.<\/jats:italic><\/jats:p>\n                <jats:p><jats:italic>\u2022 US-CT PCI of 20 or above and the involvement of particular structures such as mesentery, independently indicate incomplete resection.<\/jats:italic><\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00330-022-09242-z","type":"journal-article","created":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T13:59:35Z","timestamp":1669298375000},"page":"2800-2808","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Combined ultrasonography and CT for prognosis and predicting clinical outcomes of patients with pseudomyxoma peritonei"],"prefix":"10.1007","volume":"33","author":[{"given":"Xuedi","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiqing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xichao","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,23]]},"reference":[{"key":"9242_CR1","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1097\/01.sla.0000231705.40081.1a","volume":"245","author":"RM Smeenk","year":"2007","unstructured":"Smeenk RM, Verwaal VJ, Antonini N, Zoetmulder FA (2007) Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg 245:104\u2013109","journal-title":"Ann Surg"},{"key":"9242_CR2","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1177\/030089161209800508","volume":"98","author":"S Virzi","year":"2012","unstructured":"Virzi S, Iusco D, Bonomi S, Grassi A (2012) Pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic chemotherapy: a 7-year single-center experience. Tumori 98:588\u2013593","journal-title":"Tumori"},{"key":"9242_CR3","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/jso.23062","volume":"106","author":"N Golse","year":"2012","unstructured":"Golse N, Bakrin N, Passot G et al (2012) Iterative procedures combining cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal recurrence: postoperative and long-term results. J Surg Oncol 106:197\u2013203","journal-title":"J Surg Oncol"},{"key":"9242_CR4","doi-asserted-by":"crossref","unstructured":"Ma R, Lu D, Wang B et al (2021) Complete cytoreductive surgery vs. debulking surgery for pseudomyxoma peritonei of appendiceal origin: a propensity score-matched study based on a single-center experience. Eur J Surg Oncol 47:2369\u20132376","DOI":"10.1016\/j.ejso.2021.05.015"},{"key":"9242_CR5","doi-asserted-by":"crossref","unstructured":"Benhaim L, Faron M, Gelli M et al (2019) Survival after complete cytoreductive surgery and HIPEC for extensive pseudomyxoma peritonei. Surg Oncol 29:78\u201383","DOI":"10.1016\/j.suronc.2019.03.004"},{"key":"9242_CR6","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1002\/bjs.10723","volume":"105","author":"G Passot","year":"2018","unstructured":"Passot G, Dumont F, Go\u00e9r\u00e9 D et al (2018) Multicentre study of laparoscopic or open assessment of the peritoneal cancer index (BIG-RENAPE). Br J Surg 105:663\u2013667","journal-title":"Br J Surg"},{"key":"9242_CR7","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S1470-2045(05)70539-8","volume":"7","author":"PH Sugarbaker","year":"2006","unstructured":"Sugarbaker PH (2006) New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome? Lancet Oncol 7:69\u201376","journal-title":"Lancet Oncol"},{"key":"9242_CR8","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1245\/s10434-017-6275-7","volume":"25","author":"M Bouquot","year":"2018","unstructured":"Bouquot M, Dohan A, Gayat E et al (2018) Prediction of resectability in pseudomyxoma peritonei with a new CT score. Ann Surg Oncol 25:694\u2013701","journal-title":"Ann Surg Oncol"},{"key":"9242_CR9","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1245\/s10434-018-7007-3","volume":"26","author":"C Munoz-Zuluaga","year":"2019","unstructured":"Munoz-Zuluaga C, Sardi A, King MC et al (2019) Outcomes in peritoneal dissemination from signet ring cell carcinoma of the appendix treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol 26:473\u2013481","journal-title":"Ann Surg Oncol"},{"key":"9242_CR10","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ejso.2019.02.030","volume":"47","author":"RN Low","year":"2021","unstructured":"Low RN, Barone RM, Rousset P (2021) Peritoneal MRI in patients undergoing cytoreductive surgery and HIPEC: history, clinical applications, and implementation. Eur J Surg Oncol 47:65\u201374","journal-title":"Eur J Surg Oncol"},{"key":"9242_CR11","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.ejso.2016.01.005","volume":"42","author":"B Menassel","year":"2016","unstructured":"Menassel B, Duclos A, Passot G et al (2016) Preoperative CT and MRI prediction of non-resectability in patients treated for pseudomyxoma peritonei from mucinous appendiceal neoplasms. Eur J Surg Oncol 42:558\u2013566","journal-title":"Eur J Surg Oncol"},{"key":"9242_CR12","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1080\/02656736.2017.1310938","volume":"33","author":"R Mittal","year":"2017","unstructured":"Mittal R, Chandramohan A, Moran B (2017) Pseudomyxoma peritonei: natural history and treatment. Int J Hyperthermia 33:511\u2013519","journal-title":"Int J Hyperthermia"},{"key":"9242_CR13","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1245\/s10434-014-4041-7","volume":"22","author":"RN Low","year":"2015","unstructured":"Low RN, Barone RM, Lucero J (2015) Comparison of MRI and CT for predicting the Peritoneal Cancer Index (PCI) preoperatively in patients being considered for cytoreductive surgical procedures. Ann Surg Oncol 22:1708\u20131715","journal-title":"Ann Surg Oncol"},{"key":"9242_CR14","doi-asserted-by":"publisher","first-page":"690178","DOI":"10.3389\/fonc.2021.690178","volume":"11","author":"L Liang","year":"2021","unstructured":"Liang L, Han X, Zhou N et al (2021) Ultrasound for preoperatively predicting pathology grade, complete cytoreduction possibility, and survival outcomes of pseudomyxoma peritonei. Front Oncol 11:690178","journal-title":"Front Oncol"},{"key":"9242_CR15","doi-asserted-by":"crossref","unstructured":"Horvath P, Yurttas C, Birk P, Struller F, Konigsrainer A (2018) Cellularity in low-grade pseudomyxoma peritonei impacts recurrence-free survival following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Langenbecks Arch Surg 403:985\u2013990","DOI":"10.1007\/s00423-018-1735-5"},{"key":"9242_CR16","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.ejso.2016.03.015","volume":"42","author":"L Villeneuve","year":"2016","unstructured":"Villeneuve L, Thivolet A, Bakrin N et al (2016) A new internet tool to report peritoneal malignancy extent. PeRitOneal MalIgnancy Stage Evaluation (PROMISE) application. Eur J Surg Oncol 42:877\u2013882","journal-title":"Eur J Surg Oncol"},{"key":"9242_CR17","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1007\/s13193-019-00914-9","volume":"10","author":"G Goswami","year":"2019","unstructured":"Goswami G, Kammar P, Mangal R, Shaikh S, Patel MD, Bhatt A (2019) Accuracy of CT scan in predicting the surgical PCI in patients undergoing cytoreductive surgery with\/without HIPEC-a prospective single institution study. Indian J Surg Oncol 10:296\u2013302","journal-title":"Indian J Surg Oncol"},{"key":"9242_CR18","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1053\/ejso.2000.1038","volume":"27","author":"PH Sugarbaker","year":"2001","unstructured":"Sugarbaker PH (2001) Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome. Eur J Surg Oncol 27:239\u2013243","journal-title":"Eur J Surg Oncol"},{"key":"9242_CR19","doi-asserted-by":"crossref","unstructured":"Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205\u2013213","DOI":"10.1097\/01.sla.0000133083.54934.ae"},{"key":"9242_CR20","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1590\/0100-3984.2019.0044","volume":"52","author":"C Fonseca","year":"2019","unstructured":"Fonseca C, Carvalho S, Cunha TM, Gil RT, Abecasis N (2019) The many faces of pseudomyxoma peritonei: a radiological review based on 30 cases. Radiol Bras 52:372\u2013377","journal-title":"Radiol Bras"},{"key":"9242_CR21","doi-asserted-by":"crossref","unstructured":"Krause J, Bergman A, Graf W, Nilsson A, Mahteme H (2012) Ultrasonography findings and tumour quantification in patients with pseudomyxoma peritonei. Eur J Radiol 81:648\u2013651","DOI":"10.1016\/j.ejrad.2011.01.033"},{"key":"9242_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jso.23329","volume":"108","author":"S Kusamura","year":"2013","unstructured":"Kusamura S, Hutanu I, Baratti D, Deraco M (2013) Circulating tumor markers: predictors of incomplete cytoreduction and powerful determinants of outcome in pseudomyxoma peritonei. J Surg Oncol 108:1\u20138","journal-title":"J Surg Oncol"},{"key":"9242_CR23","doi-asserted-by":"crossref","unstructured":"Flicek K, Ashfaq A, Johnson CD, Menias C, Bagaria S, Wasif N (2016) Correlation of radiologic with surgical peritoneal cancer index scores in patients with pseudomyxoma peritonei and peritoneal carcinomatosis: how well can we predict resectability? J Gastrointestinal Surg 20:307\u2013312","DOI":"10.1007\/s11605-015-2880-6"},{"key":"9242_CR24","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1007\/s13193-016-0516-2","volume":"7","author":"V Ramaswamy","year":"2016","unstructured":"Ramaswamy V (2016) Pathology of mucinous appendiceal tumors and pseudomyxoma peritonei. Indian J Surg Oncol 7:258\u2013267","journal-title":"Indian J Surg Oncol"},{"key":"9242_CR25","doi-asserted-by":"crossref","unstructured":"Engbersen MP, Van' TSI, Lok C et al (2019) MRI with diffusion-weighted imaging to predict feasibility of complete cytoreduction with the peritoneal cancer index (PCI) in advanced stage ovarian cancer patients. Eur J Radiol 114:146-151","DOI":"10.1016\/j.ejrad.2019.03.007"},{"key":"9242_CR26","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1016\/j.ejso.2019.03.001","volume":"45","author":"M Barral","year":"2019","unstructured":"Barral M, El SI, Eveno C et al (2019) Post-operative wall shear stress in the superior mesenteric artery: biomarker of long term outcome in patients with residual disease after incomplete cytoreductive surgery for pseudomyxoma peritonei. Eur J Surg Oncol 45:1727\u20131733","journal-title":"Eur J Surg Oncol"},{"key":"9242_CR27","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1016\/j.ejso.2017.05.015","volume":"43","author":"A Dohan","year":"2017","unstructured":"Dohan A, Barral M, Eveno C et al (2017) Prediction of clinical outcome using blood flow volume in the superior mesenteric artery in patients with pseudomyxoma peritonei treated by cytoreductive surgery. Eur J Surg Oncol 43:1932\u20131938","journal-title":"Eur J Surg Oncol"},{"key":"9242_CR28","doi-asserted-by":"crossref","unstructured":"Liu Y, Zhang H, Li X, Qi G (2016) Combined application of ultrasound and CT increased diagnostic value in female patients with pelvic masses. Comput Math Methods Med 2016:6146901","DOI":"10.1155\/2016\/6146901"},{"key":"9242_CR29","doi-asserted-by":"publisher","first-page":"6148","DOI":"10.3390\/cancers13236148","volume":"13","author":"M Maurer-Granofszky","year":"2021","unstructured":"Maurer-Granofszky M, Schumich A, Buldini B et al (2021) An extensive quality control and quality assurance (QC\/QA) program significantly improves inter-laboratory concordance rates of flow-cytometric minimal residual disease assessment in acute lymphoblastic leukemia: an I-BFM-FLOW-Network Report. Cancers (Basel) 13:6148","journal-title":"Cancers (Basel)"},{"key":"9242_CR30","doi-asserted-by":"crossref","unstructured":"Bai M, Wang S, Liang G et al (2022) Nomogram to predict incomplete cytoreduction for pseudomyxoma peritonei. Ann Surg Oncol 29:885\u2013892","DOI":"10.1245\/s10434-021-10725-4"},{"key":"9242_CR31","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1177\/145749691009900406","volume":"99","author":"P Jarvinen","year":"2010","unstructured":"Jarvinen P, Lepisto A (2010) Clinical presentation of pseudomyxoma peritonei. Scand J Surg 99:213\u2013216","journal-title":"Scand J Surg"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-022-09242-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-022-09242-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-022-09242-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T13:07:57Z","timestamp":1678885677000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-022-09242-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,23]]},"references-count":31,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["9242"],"URL":"https:\/\/doi.org\/10.1007\/s00330-022-09242-z","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,23]]},"assertion":[{"value":"17 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The scientific guarantor of this publication is Lei Liang.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No complex statistical methods were necessary for this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was obtained from all patients in this study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was obtained.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"\u2022 retrospective\u2022 diagnostic or prognostic study\u2022 performed at one institution","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}